In VivoBiopharma merger and acquisition value for the fourth quarter of 2024 reached $9.4bn from 34 transactions, 15 of which had disclosed values. At the top was H. Lundbeck’s $2.6bn purchase of publicly tr
Medtech Insight[ Editor’s Note: This article was updated on 14 December with additional commentary from securities analysts that arrived after publication of the original version on 13 December. ] Integra LifeSci
Medtech InsightAs first signaled in mid-2018, General Electric has completed the separation of its health care business. GE HealthCare Technologies was launched on 3 January 2023 and GE Healthcare began trading
In VivoAs first signaled in mid-2018, General Electric has completed the separation of its health care business. GE HealthCare Technologies Inc. was launched on 3 January 2023 and GE HealthCare began tradi